Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...

AI mania has taken the world by storm, with the game-changing tech seemingly poised to permeate almost every aspect of our ...

Griffin voiced his concern over Trump's approach towards tariffs, stating that the "bombastic rhetoric" has already caused ...

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

A microchip materials manufacturer that counts Taiwan Semiconductor, GlobalFoundries and STMicroelectronics as clients saw ...

Citadel, the hedge fund giant run by Ken Griffin, had a short position equal to 0.6% of the company, according to a disclosure form filed with France's stock-market regulator earlier this week.

Ken Griffin’s Citadel wins big. Soitec cites worsening automotive market for warning. Last Updated: Feb. 6, 2025 at 6:38 a.m. ET First Published: Feb. 6, 2025 at 5:48 a.m. ET ...

Feb 14 (Reuters) - Billionaire Ken Griffin's hedge fund Citadel has taken a short position ... 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, according to data ...

After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...